2005
DOI: 10.1016/j.fmrre.2004.12.006
|View full text |Cite
|
Sign up to set email alerts
|

Enzyme genomics: Application of general enzymatic screens to discover new enzymes

Abstract: In all sequenced genomes, a large fraction of predicted genes encodes proteins of unknown biochemical function and up to 15% of the genes with ''known'' function are mis-annotated. Several global approaches are routinely employed to predict function, including sophisticated sequence analysis, gene expression, protein interaction, and protein structure. In the first coupling of genomics and enzymology, Phizicky and colleagues undertook a screen for specific enzymes using large pools of partially purified protei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
40
2
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 103 publications
(44 citation statements)
references
References 108 publications
1
40
2
1
Order By: Relevance
“…[7] Despite its potent activity against Gram-negative bacteria, the clinical use of CL is rather limited because of its adverse effects,s uch as bone marrow suppression. [11] Based on the above rationale,weconjugated the simplest dipeptide,d iglycine (GG), with CLsu to create an ew conjugate CLsuGG.B esides exhibiting about 10 times higher inhibitory activity than CLsu against E. coli,CLsuGG shows lower cytotoxicity than CL towards bone marrow stromal cells.M echanistic studies confirm that ap rotoncoupled and bacterial specific oligopeptide transporter, YdgR, [12] is involved in the uptake of CLsuGG.M ore importantly,CLsuGG is rapidly hydrolyzed by intrabacterial esterases (for example,BioH [13] and YjfP [14] )toregenerate CL (Scheme 1). [10] One strategy to address the problem is to enhance the uptake and increase the retention time of CL inside the bacteria by conjugating it with ad ipeptide because Gram-negative bacteria express oligopeptide transporters for the uptake of di-and tripeptides.…”
mentioning
confidence: 98%
“…[7] Despite its potent activity against Gram-negative bacteria, the clinical use of CL is rather limited because of its adverse effects,s uch as bone marrow suppression. [11] Based on the above rationale,weconjugated the simplest dipeptide,d iglycine (GG), with CLsu to create an ew conjugate CLsuGG.B esides exhibiting about 10 times higher inhibitory activity than CLsu against E. coli,CLsuGG shows lower cytotoxicity than CL towards bone marrow stromal cells.M echanistic studies confirm that ap rotoncoupled and bacterial specific oligopeptide transporter, YdgR, [12] is involved in the uptake of CLsuGG.M ore importantly,CLsuGG is rapidly hydrolyzed by intrabacterial esterases (for example,BioH [13] and YjfP [14] )toregenerate CL (Scheme 1). [10] One strategy to address the problem is to enhance the uptake and increase the retention time of CL inside the bacteria by conjugating it with ad ipeptide because Gram-negative bacteria express oligopeptide transporters for the uptake of di-and tripeptides.…”
mentioning
confidence: 98%
“…A.3 Crystal structure of pNPP-Na pNPP has been used for decades as a marker of phosphatase activity, as described in Chapter 4. pNPP was originally employed clinically in the detection of alkaline phosphatase activity in blood serum (Bessey et al, 1946) and is used today as a general indicator of phosphohydrolase activity. The anion is a component of a set of general enzymatic screens against libraries of proteins of unknown function (Kuznetsova et al, 2005), and was used to originally determine the function of YfbR as a phosphohydrolase (Chapter 4).…”
Section: A2 Methods and Resultsmentioning
confidence: 99%
“…A number of membraneassociated, periplasmic and extracellular bacterial 5'-NTs have been identified and purified, but few have been extensively characterized, such as UshA from E. coli, NucA from Haemophilus influenzae (Zagursky et al, 2000), or HppA from Helicobacter pylori (Reilly & Calcutt, 2004). Recently, using a systematic general enzymatic screen against a large set of purified bacterial proteins (Kuznetsova et al, 2005), three of the first intracellular bacterial 5'-NTs were identified in E. coli: SurE, YjjG, and YfbR. SurE is a 5'(3')-nucleotidase and a member of a conserved domain found in prokaryotes and eukaryotes.…”
Section: The Hydrolysis Was Measured As Free Phosphate Released Per Mmentioning
confidence: 99%
See 2 more Smart Citations